Director Carni Orna files initial Form 3 at SHL Telemedicine (SHMLF) with no trades

Rhea-AI Filing Summary

SHL Telemedicine Ltd director Carni Orna has filed an initial statement of beneficial ownership on Form 3. The filing, as summarized here, does not list any reportable transactions or derivative positions, indicating this is a baseline disclosure of insider status rather than an active trade.

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Carni Orna

(Last) (First) (Middle)

HAMEYASDIM 14

(Street)

ARUGUT 7986400

(City) (State) (Zip)

ISRAEL

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
SHL TELEMEDICINE LTD [ SHLT ]

3a. Foreign Trading Symbol
[SHLTN]

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

(1) This Form 3 is filed pursuant to the Holding Foreign Insiders Accountable Act (HFIAA), which extends Section 16(a) reporting obligations to directors and officers of Foreign Private Issuers effective March 18, 2026.

No securities are beneficially owned.

	/s/ Carni Orna	03/21/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the SHMLF Form 3 filing by Carni Orna show?

The Form 3 shows that Carni Orna is a director of SHL Telemedicine Ltd and is filing an initial beneficial ownership statement. The summarized data contains no reportable transactions or derivative positions, indicating a baseline regulatory disclosure rather than an active trade.

Did Carni Orna buy or sell SHL Telemedicine (SHMLF) shares in this Form 3?

No transactions are reported for Carni Orna in this Form 3 summary. The filing records her status as a director of SHL Telemedicine Ltd without listing purchases, sales, or derivative exercises, making it an administrative ownership disclosure rather than a trading notice.

What insider role does Carni Orna have at SHL Telemedicine Ltd (SHMLF)?

Carni Orna is identified as a director of SHL Telemedicine Ltd in this Form 3. She is not reported as an officer or ten percent owner in the provided data, so the filing focuses on her board-level insider status for regulatory ownership reporting purposes.

Does the SHL Telemedicine Form 3 include any derivative securities for Carni Orna?

The summarized Form 3 data shows no derivative positions for Carni Orna. The derivative section is empty and derivative transaction counts are zero, indicating there are no stock options, warrants, or similar instruments reported for her in this particular ownership statement.

What does the transaction summary in SHMLF’s Form 3 indicate?

The transaction summary shows zero buys, zero sells, and zero exercises, with net shares listed as neutral. This means the Form 3 serves as an initial ownership record for director Carni Orna, without any associated trading activity in the disclosed period.